查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363222

临床微生物学市场规模、份额、趋势分析报告：按产品、按疾病、按地区、细分市场趋势，2023-2030

Clinical Microbiology Market Size, Share & Trends Analysis Report By Product, By Disease (Bloodstream, Respiratory, Gastrointestinal, Periodontal, STD, UTI), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 94 Pages | 商品交期: 2-10个工作天内

价格

临床微生物学市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球临床微生物学市场规模预计将达到76亿美元，预测期内年复合成长率为7.1%。

预计在预测期内年复合成长率为 6.7%。临床微生物学依赖技术和熟练的劳动力来处理临床检体和解释结果。临床工作人员因测试週转时间 (TAT) 不佳而感到沮丧。然而，随着技术的进步，许多测试仪器和设备正在被自动化设备取代，以最大限度地减少人为错误和对技术纯熟劳工的依赖。

此外，自动化还具有诸如更快的 TAT 以及减少劳动力和实验室空间使用等优点，从而可以降低与这些测试相关的整体成本。每个製造商都专注于引入自动化检体处理、板读取和生物鉴定。 GE Healthcare、PerkinElmer 和 Thermo Fisher 是诊断产业提供自动化系统的主要企业。

医院获得性感染（HAI）的增加也推动了对临床微生物学诊断和监测的需求。随着高所得国家加强控制医院感染，低收入和中等收入国家也意识到了这个威胁。自动化系统和创新设计的引入预计将在预测期内加剧市场竞争并改变市场动态。

世界卫生组织 (WHO) 在 HAI 发病率在 2.5% 至 14.8% 之间的国家尤其活跃，包括衣索比亚、布吉纳法索、奈及利亚、阿尔及利亚和塞内加尔。因此，这些国家对 HAI 诊断的需求正在增加。印度、斯里兰卡、巴基斯坦和不丹等国家也积极参与 HAI 意识计画。预计印度和中国将成为未来几年推动 HAI 诊断设备和测试需求的主要国家。

临床微生物学市场报告亮点

  • 预计分子诊断设备领域在预测期内将呈现最快的成长速度。这种增长是由于分子诊断在癌症和感染疾病早期检测中的重要性日益增加。
  • 由于重复购买试剂，试剂在 2022 年获得了最大的收益占有率。
  • 2022年，北美将主导全球市场。对感染疾病治疗的持续研究以及政府医疗机构随后的津贴正在为该地区强大生态系统的发展做出贡献。
  • 由于印度、中国和日本老年人口不断增加，预计亚太地区将成为预测期内成长最快的地区。结果，结核病、霍乱、伤寒等感染疾病再次出现。

目录

第1章调查方法和范围

第2章执行摘要

第3章临床微生物学市场变数、趋势、范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 普及和成长预测图
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 临床微生物学市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章临床微生物：按产品估算和趋势分析

  • 临床微生物学市场：要点
  • 临床微生物学市场：2022 年和 2030 年趋势和市场占有率分析
  • 实验室设备
    • 孵化器
    • 革兰氏染色
    • 细菌菌落计数器
    • 高压灭菌器
    • 培养皿填充物
  • 自动化文化
    • 微生物分析仪
    • 分子诊断设备
    • 显微镜
    • 质谱仪
  • 试剂

第5章临床微生物：依疾病分类的估计与趋势分析

  • 临床微生物学市场：要点
  • 临床微生物学市场：2022 年和 2030 年趋势和市场占有率分析
  • 呼吸系统疾病
  • 血流感染疾病
  • 消化系统疾病
  • 性行为感染传染病
  • 尿道感染
  • 牙周
  • 其他疾病

第6章临床微生物学市场：区域估计与趋势分析

  • 区域展望
  • 按地区分類的临床微生物学市场：要点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第7章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • BIOMERIEUX
    • Cepheid.
    • Danaher Corporation
    • Bruker Corporation
    • BD
    • Hologic, Inc.
    • F. Hoffmann-La Roche Ltd
    • Alere, Inc.
Product Code: GVR-1-68038-142-9

Clinical Microbiology Market Growth & Trends:

The global clinical microbiology market size is expected to reach USD 7.6 billion by 2030, registering a CAGR of 7.1% during the forecast period, according to a new report by Grand View Research, Inc.. It is projected to expand at a CAGR of 6.7% over the forecast period. Clinical microbiology depends on technical and skilled workforce to process and interpret results of clinical specimens. Clinical staff have been complaining about poor Turnaround Time (TAT) of tests. However, with technological advancements, a number of laboratory instruments and equipment are being replaced with automated devices to minimize human error and dependency on skilled workforce.

In addition, automation has benefits such as reduced TAT and use of labor and lab space, thereby reducing overall cost associated with these tests. Manufacturers are focusing on introduction of automatic specimen processing, plate reading, and organism identification. GE Healthcare, PerkinElmer, and Thermo Fisher are some of the key players offering automated systems in the diagnostics industry.

Rising cases of hospital-acquired infections (HAI) is also fueling demand for clinical microbiology for diagnosis and monitoring. As high-income countries are stepping up their pursuit of countering hospital-acquired infections, middle- and low-income countries are recognizing the threat. Introduction of automated systems and innovative designs is expected to intensify market competition and change market dynamics over the forecast period.

The World Health Organization (WHO) is particularly active in countries such as Ethiopia, Burkina Faso, Nigeria, Algeria, and Senegal, where occurrence of HAIs ranged between 2.5% and 14.8%. This has led to increased demand for HAI diagnostics in these countries. Countries such as India, Sri Lanka, Pakistan, and Bhutan are also actively participating in HAI awareness programs. India and China are projected to be the main countries driving demand for HAI diagnostics instruments and tests in future.

Clinical Microbiology Market Report Highlights:

  • The molecular diagnostic instruments segment is expected to exhibit the fastest growth rate over the forecast period. This growth can be attributed to the increasing significance of molecular diagnosis in the early detection of cancer and infectious diseases.
  • Reagents captured the largest revenue share in 2022 owing to repeat purchase of reagents
  • In 2022, North America dominated the global market. Continuous research on infectious disease treatment and subsequent grants from government healthcare agencies are contributing to development of a strong ecosystem in the region
  • Asia Pacific is expected to emerge as the fastest growing region during the forecast period owing to rising geriatric population in India, China, and Japan. This has resulted in high prevalence of re-emerging infectious diseases such as tuberculosis, cholera, and typhoid

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Disease
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Disease outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Microbiology Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Clinical Microbiology Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Clinical Microbiology : Product Estimates & Trend Analysis

  • 4.1. Clinical Microbiology Market: Key Takeaways
  • 4.2. Clinical Microbiology Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Laboratory Instruments
    • 4.3.1. Laboratory instruments market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.2. Incubators
      • 4.3.2.1. Incubators market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.3. Gram stainers
      • 4.3.3.1. Gram stainers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.4. Bacterial colony counters
      • 4.3.4.1. Bacterial colony counters market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.5. Autoclave sterilizers
      • 4.3.5.1. Autoclave sterilizers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.6. Petri dish fillers
      • 4.3.6.1. Petri dish fillers market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Automated Culture
    • 4.4.1. Automated culture market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Microbiology analyzers
      • 4.4.2.1. Microbiology analyzers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Molecular diagnostic instruments
      • 4.4.3.1. Molecular diagnostic instruments market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.4. Microscopes
      • 4.4.4.1. Microscopes market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.5. Mass spectrometers
      • 4.4.5.1. Mass spectrometers market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Reagents
    • 4.5.1. Reagents market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Clinical Microbiology: Disease Estimates & Trend Analysis

  • 5.1. Clinical Microbiology Market: Key Takeaways
  • 5.2. Clinical Microbiology Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Respiratory Diseases
    • 5.3.1. Respiratory diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Bloodstream Infections
    • 5.4.1. Bloodstream infections market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Gastrointestinal Diseases
    • 5.5.1. Gastrointestinal diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Sexually Transmitted Diseases
    • 5.6.1. Sexually transmitted diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Urinary Tract Infections
    • 5.7.1. Urinary tract infections market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. Periodontal Diseases
    • 5.8.1. Periodontal diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.9. Other Diseases
    • 5.9.1. Other diseases market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Clinical Microbiology Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Clinical Microbiology Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Denmark
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. BIOMERIEUX
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Cepheid.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Danaher Corporation
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Bruker Corporation
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. BD
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Hologic, Inc.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. F. Hoffmann-La Roche Ltd
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Alere, Inc.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 4 North America clinical microbiology market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 6 U.S. clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 7 Canada clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 8 Canada clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 9 Europe clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 10 Europe clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 11 Europe clinical microbiology market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 13 Germany clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 14 UK clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 15 UK clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 16 France clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 17 France clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 18 Italy clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 19 Italy clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 20 Spain clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 21 Spain clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 22 Denmark clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 23 Denmark clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 24 Sweden clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 25 Sweden clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 26 Norway clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 27 Norway clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific clinical microbiology market, by region, 2018 - 2030 (USD Million)
  • Table 31 Japan clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 32 Japan clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 33 China clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 34 China clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 35 India clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 36 India clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 37 Australia clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 38 Australia clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 39 Thailand clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 40 Thailand clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 41 South Korea clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 42 South Korea clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 43 Latin America clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 44 Latin America clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 45 Latin America clinical microbiology market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 47 Brazil clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 48 Mexico clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 49 Mexico clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 50 Argentina clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 51 Argentina clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa clinical microbiology market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 56 South Africa clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 59 UAE clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 60 UAE clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 61 Kuwait clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 62 Kuwait clinical microbiology market, by disease, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Clinical Microbiology: Market outlook
  • Fig. 9 Clinical Microbiology: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Clinical microbiology market driver impact
  • Fig. 15 Clinical microbiology market restraint impact
  • Fig. 16 Clinical microbiology market strategic initiatives analysis
  • Fig. 17 Clinical microbiology market: Product movement analysis
  • Fig. 18 Clinical microbiology market: product outlook and key takeaways
  • Fig. 19 Laboratory instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Incubators market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Gram stainers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Bacterial colony counters market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Autoclave sterilizers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Petri dish fillers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Automated culture systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Microbiology analyzers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Molecular diagnostic instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Microscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Mass spectrometers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Clinical microbiology market: Disease movement analysis
  • Fig. 32 Clinical microbiology market: disease outlook and key takeaways
  • Fig. 33 Respiratory diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Bloodstream infections market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Gastrointestinal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Sexually transmitted diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Urinary tract infections market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Periodontal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Other diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Global clinical microbiology market: Regional movement analysis
  • Fig. 41 Global clinical microbiology market: Regional outlook and key takeaways
  • Fig. 42 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)